Chronic thromboembolic pulmonary hypertension: a review of current practice.

Abstract:

:Pulmonary artery hypertension is a complex and multi-faceted disease process with numerous etiologies. Chronic thromboembolic pulmonary hypertension (CTEPH) is an underdiagnosed and highly treatable form of pulmonary hypertension. In this disease, certain patients with a history of pulmonary thromboembolic disease go on to develop elevated pulmonary artery pressures, shortness of breath, and progressive right heart failure. This article will review the epidemiology, pathophysiology, diagnosis and treatment of CTEPH with a review of pulmonary thromboendarterectomy surgery.

journal_name

Prog Cardiovasc Dis

authors

Haythe J

doi

10.1016/j.pcad.2012.07.005

subject

Has Abstract

pub_date

2012-09-01 00:00:00

pages

134-43

issue

2

eissn

0033-0620

issn

1873-1740

pii

S0033-0620(12)00129-6

journal_volume

55

pub_type

杂志文章,评审
  • Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer.

    abstract::Due to advances in prevention, early detection and treatment, early breast cancer mortality has decreased by nearly 40% during the last four decades. Yet, the risk of cardiovascular disease (CVD) mortality is significantly elevated following a breast cancer diagnosis, and it is a leading cause of death in this populat...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.02.002

    authors: Kirkham AA,Beaudry RI,Paterson DI,Mackey JR,Haykowsky MJ

    更新日期:2019-01-01 00:00:00

  • How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors.

    abstract::There is a strong evidence that more marked lowering of low-density lipoprotein cholesterol (LDL-C) leads to progressively lower risk of cardiovascular disease (CVD) events. The evidence on validity of this hypothesis comes from epidemiological, genetic and clinical studies. The hypothesis "the lower the better" has b...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.12.008

    authors: Cybulska B,Kłosiewicz-Latoszek L,Penson PE,Nabavi SM,Lavie CJ,Banach M,International Lipid Expert Panel (ILEP).

    更新日期:2020-12-28 00:00:00

  • The 'perfect storm' and acute coronary syndrome onset: do psychosocial factors play a role?

    abstract::The revolution in cardiac care over the past two decades, characterized by emergent revascularization, drug eluting stents, anti-platelet medications, and advanced imaging has had little impact on overall ACS recurrence, or ACS prevention. The "Perfect Storm" refers to a confluence of events and processes, including a...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.03.003

    authors: Burg MM,Edmondson D,Shimbo D,Shaffer J,Kronish IM,Whang W,Alcántara C,Schwartz JE,Muntner P,Davidson KW

    更新日期:2013-05-01 00:00:00

  • Symptomatic Carotid Artery Disease: Revascularization.

    abstract::Patients with symptomatic carotid artery disease should be managed by a multidisciplinary team including neurologists, vascular surgeons and interventionalists. Duplex ultrasound is the most widely used diagnostic modality to assess carotid disease, followed by additional imaging tests (CT- or MR-angiography) to confi...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.04.002

    authors: Montorsi P,Galli S,Ravagnani PM,Roffi M

    更新日期:2017-01-01 00:00:00

  • Interventional echocardiography.

    abstract::Echocardiography guidance for interventions in the catheterization laboratory allows for reduction in radiation exposure from fluoroscopy as well as superior anatomic definition and visualization. The additional information provided over fluoroscopy has translated into an increasing use during interventional procedure...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2014.05.009

    authors: Pislaru SV,Michelena HI,Mankad SV

    更新日期:2014-07-01 00:00:00

  • Obesity and Kidney Disease.

    abstract::Obesity is a systemic disease of the white adipose tissue, which has evolved into a global epidemic. It is associated with a plethora of adipocyte hormonal (adipokine) imbalances, dysregulation of the energy-balance system, imbalances in metabolic homeostasis, a pro-inflammatory state and multiple target organ damages...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.07.005

    authors: Lakkis JI,Weir MR

    更新日期:2018-01-01 00:00:00

  • Systolic dysfunction in heart failure with normal ejection fraction: speckle-tracking echocardiography.

    abstract::Left ventricular (LV) ejection fraction (EF) and LV end-systolic volumes are important measures of LV global function. However, in many patients with symptoms of heart failure, these measures are within normal limits. This condition is classified as heart failure with normal ejection fraction (HFNEF). Reduced EF and i...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2006.08.008

    authors: Edvardsen T,Helle-Valle T,Smiseth OA

    更新日期:2006-11-01 00:00:00

  • Noninvasive assessment of atherosclerosis.

    abstract::The application of ultrasound to clinical evaluation of the symptomatic patient requires less precision and accuracy than when it is used as an instrument to study atherogenesis. The clinician's goal is to locate hemodynamically significant lesions; studies of atherogenesis require auxometry (measurement of the growth...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章

    doi:10.1016/0033-0620(84)90007-0

    authors: Blankenhorn DH,Rooney JA,Curry PJ

    更新日期:1984-01-01 00:00:00

  • An Update on the Role of Cardiorespiratory Fitness, Structured Exercise and Lifestyle Physical Activity in Preventing Cardiovascular Disease and Health Risk.

    abstract::The cardiovascular disease (CVD) pandemic has placed considerable strain on healthcare systems, quality of life, and physical function, while remaining the leading cause of death globally. Decades of scientific investigations have fortified the protective effects of cardiorespiratory fitness (CRF), exercise training, ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.11.005

    authors: Ozemek C,Laddu DR,Lavie CJ,Claeys H,Kaminsky LA,Ross R,Wisloff U,Arena R,Blair SN

    更新日期:2018-01-01 00:00:00

  • Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?

    abstract::Tumor necrosis factor alpha (TNF-alpha), a protein belonging to the family of cytokines, is one of the leading mediators of the immune response to inflammation. Its widespread biological effects are modulated by two circulating binding proteins corresponding to the extracellular domain of the membrane receptors, namel...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80028-5

    authors: Ceconi C,Curello S,Bachetti T,Corti A,Ferrari R

    更新日期:1998-07-01 00:00:00

  • Stress nuclear myocardial perfusion imaging versus stress echocardiography: prognostic comparisons.

    abstract::The use of noninvasive stress cardiac imaging for stratifying risk in patients with known or suspected coronary artery disease is growing as a tool for identification of the subgroup most likely to benefit from the expense and risk of more invasive procedures, including cardiac catheterization and coronary revasculari...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.19314

    authors: Brown KA,Rosman DR,Dave RM

    更新日期:2000-11-01 00:00:00

  • Exploring predisposition and treatment response--the promise of genomics.

    abstract::Spurred by large-scale public and private efforts as well as technological developments, the last few years have seen a major leap forward in our understanding of the genetic basis of cardiovascular disease. This revolution is in its infancy and will continue to alter the medical landscape for years to come. There is ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.04.006

    authors: Pan S,Knowles JW

    更新日期:2012-07-01 00:00:00

  • The use of echocardiography for quantitative evaluation of left ventricular function.

    abstract::Echocardiography is a valuable technique for the diagnosis and serial follow-up of patients with impaired cardiac function. It is subject to certain limitations due to the assumptions inherent in deriving ventricular volume from a one-dimensional measurement and must be interpreted with caution in cases of suspected r...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(78)90018-x

    authors: Mason SJ,Fortuin NJ

    更新日期:1978-09-01 00:00:00

  • Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.

    abstract::Because not all laboratories use the monitoring and stimulation protocols used in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial, we reanalyzed the ESVEM patients' data using alternative, commonly used Holter monitor (HM) and programmed stimulation efficacy criteria to determine if d...

    journal_title:Progress in cardiovascular diseases

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0033-0620(96)80029-6

    authors: Reiffel JA,Reiter MJ,Freedman RA,Mann D,Huang SK,Hahn E,Hartz V,Mason J,ESVEM Investigators.

    更新日期:1996-03-01 00:00:00

  • Diagnosis and treatment of heart disease: are women different from men?

    abstract::Key questions concerning strategies for diagnosis, prevention, and treatment of heart disease in women remain unanswered. Thrombolytic therapy has been shown to reduce mortality similarly in men and women. In addition, percutaneous coronary intervention for acute coronary syndromes is as effective in women as in men. ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2010.07.004

    authors: Xhyheri B,Bugiardini R

    更新日期:2010-11-01 00:00:00

  • Natural history of thoracic aortic aneurysms: size matters, plus moving beyond size.

    abstract::Thoracic aortic aneurysms (TAAs) are a prevalent and deadly disease that, without diagnosis and treatment, eventuates in life-threatening aortic dissection or rupture. While TAAs normally grow in an indolent manner, once a certain size (a "hinge point") is reached, the risk of dissection, rupture, and death increases ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.05.007

    authors: Chau KH,Elefteriades JA

    更新日期:2013-07-01 00:00:00

  • Percutaneous Treatment for Native Mitral Regurgitation.

    abstract::Severe mitral regurgitation (MR) confers an adverse prognosis, frequently with debilitating symptoms of heart failure. While open surgical correction has been the standard of care for decades, novel catheter-based technologies have emerged that are highly effective in the treatment of MR. These percutaneous technologi...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.11.003

    authors: Sorajja P,Maisano F

    更新日期:2017-01-01 00:00:00

  • Infective endocarditis of the mitral valve: optimal management.

    abstract::Infective endocarditis continues to be associated with significant morbidity and mortality despite recent advances in its management and remains a serious and challenging condition requiring a multidisciplinary approach. Surgery is essential in at least 50% of cases. Surgical outcomes have improved with the introducti...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2008.08.007

    authors: Zakkar M,Chan KM,Amirak E,Herrey A,Punjabi PP

    更新日期:2009-05-01 00:00:00

  • Baroreflex function in hypertension: consequences for antihypertensive therapy.

    abstract::Studies performed in experimental animal models of hypertension as well as in human hypertension have unequivocally shown that reflex cardiovascular control undergoes profound changes with high blood pressure and participates throughout direct and indirect mechanisms at the development and progression of hypertension-...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2006.03.002

    authors: Grassi G,Trevano FQ,Seravalle G,Scopelliti F,Mancia G

    更新日期:2006-05-01 00:00:00

  • The role of cardiovascular magnetic resonance in patients with acute coronary syndromes.

    abstract::Cardiovascular magnetic resonance (CMR) imaging is a recognized technique for characterization of myocardial tissue in stable ischemic heart disease. In addition, CMR is emerging as a noninvasive imaging tool that can provide supporting information to guide treatment in acute coronary syndromes (ACSs). The advantages ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2011.09.001

    authors: Dall Armellina E,Choudhury RP

    更新日期:2011-11-01 00:00:00

  • Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?

    abstract::There are >1.4 million adult congenital heart disease (CHD; ACHD) patients living in the United States. Coronary artery disease (CAD) is at least as prevalent in ACHD patients as in the general population and has become a leading cause of their mortality. In the majority of cases, CAD in the ACHD population is driven ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.07.018

    authors: Awerbach JD,Krasuski RA,Camitta MGW

    更新日期:2018-01-01 00:00:00

  • Beta blocker treatment in heart failure.

    abstract::The sympathetic nervous system occupies a prominent role in heart failure both as a marker of severity of disease and also as an important factor in its progression. Beta blocker therapy, once thought heretical in heart failure, has consistently improved cardiac function and slowed progression of disease. Large clinic...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.1999.0410301

    authors: Carson PE

    更新日期:1999-01-01 00:00:00

  • Catheter-based therapies for massive pulmonary embolism.

    abstract::Massive pulmonary embolism carries a high mortality rate as a result of right ventricular failure. In addition to anticoagulation, systemic thrombolysis is the standard first line of therapy for patients with life-threatening massive pulmonary embolism. Surgical embolectomy is often considered in patients with contrai...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2010.01.002

    authors: Todoran TM,Sobieszczyk P

    更新日期:2010-03-01 00:00:00

  • Update on Obesity and Obesity Paradox in Heart Failure.

    abstract::Obesity has reached epidemic proportions in most of the Westernized world. Overweightness and obesity adversely impact cardiac structure and function, including on both the right and, especially, left sides of the heart, with adverse affects on systolic and, especially, diastolic ventricular function. Therefore, it is...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.12.003

    authors: Lavie CJ,Sharma A,Alpert MA,De Schutter A,Lopez-Jimenez F,Milani RV,Ventura HO

    更新日期:2016-01-01 00:00:00

  • The Current Global State of Key Lifestyle Characteristics: Health and Economic Implications.

    abstract::The chronic disease crisis we currently face must be addressed in rapid fashion. Cardiovascular (CV) and pulmonary diseases, diabetes as well as several forms of cancer are leading causes of morbidity and mortality globally. Collectively, these conditions have a significant impact on the quality of life of individuals...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.02.002

    authors: Arena R,McNeil A,Sagner M,Hills AP

    更新日期:2017-01-01 00:00:00

  • Pathophysiological basis of syncope and neurological conditions that mimic syncope.

    abstract::The definition of syncope has clinical and pathophysiological parts. The clinical part is that syncope is a form of transient loss of consciousness (TLOC), while the pathophysiological element is that syncope differs from other forms of TLOC by virtue of the basis of true syncope - specifically cerebral hypoperfusion....

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.10.016

    authors: van Dijk JG,Wieling W

    更新日期:2013-01-01 00:00:00

  • Chagas cardiomyopathy--where do we stand after a hundred years?

    abstract::A hundred years from its description, Chagas cardiomyopathy remains a challenging disease. Although successful vector-control strategies have decreased the incidence of Chagas disease in several Latin American countries, both migration to urban areas and immigration have spread the disease worldwide; and now, blood tr...

    journal_title:Progress in cardiovascular diseases

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/j.pcad.2009.11.008

    authors: Biolo A,Ribeiro AL,Clausell N

    更新日期:2010-01-01 00:00:00

  • Telemedicine and advances in urban and rural healthcare delivery in Africa.

    abstract::Telecardiology holds great promise for Africa, from tele-echocardiography and tele-ECG s, to home monitoring and text messaging for medication adherence monitoring. The burden of disease is great and there is an extreme shortage of health professionals. Telemedicine can provide access to scarce specialist care, improv...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.10.006

    authors: Mars M

    更新日期:2013-11-01 00:00:00

  • Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention.

    abstract::A large number of drug trials for prevention of restenosis have been conducted with many showing little or conflicting benefit. Antiplatelets such as aspirin, ticlopidine and thromboxane A2 receptor inhibitors have not shown a clear benefit. Similarly, antithrombotics, either acting indirectly such as heparin, or as d...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(97)80006-0

    authors: Lefkovits J,Topol EJ

    更新日期:1997-09-01 00:00:00

  • Multimodality imaging in bicuspid aortic valve.

    abstract::Bicuspid aortic valve (BAV) patients are at increased risk of valve dysfunction and ascending aorta aneurysm. Imaging techniques are essential to establish diagnosis, identify complications and indicate surgical treatment. Transthoracic echocardiography (TTE) is the imaging technique of choice to diagnose BAV, valve m...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.06.003

    authors: Galian-Gay L,Rodríguez-Palomares J,Guala A,Michelena HI,Evangelista A

    更新日期:2020-01-01 00:00:00